Clinical Trial Update: Pharmacokinetic and Safety Study of Travoprost 0.004% in Pediatric Glaucoma Patients [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic and safety study of Travoprost 0.004% ophthalmic solution in pediatric glaucoma patients has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• Travoprost (Travoprost (isomer-free))

Snippet

Sponsor: Alcon Research | Conditions: Glaucoma, Ocular Hypertension | Phase 1 | Status: COMPLETED | Results posted: 2014-07-21